Home/IsomAb/Professor David Bates

PD

Professor David Bates

Chief Scientific Officer

Therapeutic Areas

IsomAb Pipeline

Drug	Indication	Phase
ISM-001	Chronic Stable Angina (Coronary Artery Disease)	Pre-clinical

Leadership Team at IsomAb

Dr Philip Brainin

Chief Executive Officer

Julian Attfield

Chief Financial Officer/Company Secretary

Dr Gary Burgess

Chief Medical Officer

View full IsomAb profile